Webinar Webinar
Menu

ConformalFLASH® - Overview

Please connect to access this resource and get a more personalized Campus experience
Connect
Executive summary

ConformalFLASH combines the biological tissue sparing effects of FLASH with physics sparing effects of Proton Bragg Peak.

IBA is investing heavily in developing this novel technique utilizing the Bragg peak called ConformalFLASH®. IBA’s strategy to take FLASH today from research to a clinical version of ConformalFLASH® will take into consideration the radiobiology, clinical safety, and future streamlined workflow for FLASH.

Flash Therapy is currently under research and development phase and will be available for sale when regulatory clearance is received.

Key content topics
FLASH Therapy
Guest speakers
Swati
Girdhani
Director of Research Collaborations​
IBA
Nicolas
Denef
Emerging Therapies Director
IBA

Related contents

Proton Therapy Publication
Proton therapy publication
October 2024
The Radiosurgery Society Working Groups on GRID, LATTICE, Microbeam, and FLASH Radiotherapies: 2022 - 2023 Advancements Symposium and Subsequent Progress Made.
Link to the fully detailed content
Proton Therapy Publication
March 2024
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.
en
Link to the fully detailed content
Proton Therapy Publication
April 2024
FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?
en
Link to the fully detailed content
Proton Therapy Publication
April 2024
Proton FLASH radiotherapy ameliorates radiation-induced salivary gland dysfunction and oral mucositis and increases survival in a mouse model of head and neck cancer.
en
Link to the fully detailed content